Immunomodulators for Bridging Peripheral Nerve Gaps
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clinical solutions fail to effectively bridge nerve gaps longer than 2-3 cm in length, enhance the rate of nerve regeneration, or improve the quality of nerve regeneration, leaving a significant clinical need for treating peripheral nerve injuries.
Innovation Solution
The use of CXCR4 antagonists, STAT3 activators, and nitric oxide-increasing agents, either alone or in combination, to promote nerve growth and regeneration, potentially accompanied by the insertion of a physical support structure, such as a tube or spongiform matrix, to bridge critical gaps in nerves.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of stationary object
If commercially available nerve regeneration products are used, then short nerve defects of less than 2-3 cm can be bridged, but nerve gaps longer than 2-3 cm cannot be effectively treated
Solution Approach 1:
The patent uses immunomodulatory drugs to change the biological parameters of the nerve injury site, specifically modulating the immune response to create a favorable environment for regeneration. This allows the treatment to be effective for longer nerve gaps by altering the biochemical conditions rather than relying solely on the physical length of the bridge
Solution Approach 2:
The patent introduces immunomodulatory drugs as intermediaries that mediate between the nerve injury and the regeneration process. These drugs modulate the immune system's response to injury, creating conditions that support nerve regeneration across longer gaps without requiring direct physical contact between nerve ends
2Productivity
If conventional nerve regeneration methods are used, then some nerve regeneration occurs, but the rate of regeneration is not enhanced
Solution Approach 1:
The patent applies immunomodulatory drugs preliminarily to prepare the injury site environment before nerve regeneration begins. By pre-modulating the immune response and creating a favorable biochemical environment in advance, the regeneration process is accelerated once it starts
Solution Approach 2:
The patent employs periodic administration of immunomodulatory drugs to sustain the favorable environment for regeneration over time. This periodic treatment maintains the biochemical conditions necessary for accelerated nerve growth throughout the regeneration process
3Reliability
If conventional nerve regeneration methods are used, then some regeneration occurs, but the quality of regeneration is not improved
Solution Approach 1:
The immunomodulatory drugs serve as intermediaries that improve regeneration quality by mediating the immune response. Rather than complexing the treatment with multiple physical interventions, the patent uses biochemical mediation to enhance the quality of nerve regeneration through immune system modulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables nerve regeneration across gaps greater than 3 cm without the need for exogenous cells or scaffolds, improving sensory and motor function by stimulating neural cell growth and regeneration.
Implementation Method 1
administering to said subject singly, or in combination, a CXCR4 antagonist, a STAT3 activator, and/or an agent that increases nitric oxide content
Data Source
AI summary
The present disclosure describes the use of immune modulators to promote nerve growth and regeneration, particularly in the context of nerve deficit stemming from trauma and disease. In particular, the disclosure provides for the use of CXCR4 antagonists, STAT3 activators, and an agent that increases levels of nitric oxide, either alone or in any combination of these drugs, in surgery performed to treat nerve deficit conditions, especially peripheral nerve deficit conditions caused by cut injury or tear injury, the method especially useful in bridging nerve gaps of 3 cm or longer.